HA
Invalid date
This course provided me to look to the pharmaceutical industry with a broader perspective. Thank you to the course organization and all the speakers.
RS
Invalid date
Very helpful course if you`re planning to make a career in pharma. Gave a lot of insights on topics like drug commercialisation, regulatory, partnership, etc.
By Mansour M E M
•Apr 18, 2020
thank you very clear and interesting courses
By Mahi P
•Aug 3, 2020
i found it very useful and innovative
By Sunaina R
•May 1, 2020
Very informative, a 100% recommended.
By Khairul S M A
•Sep 28, 2020
a great course with experts opinion
By Sabhashina d R K
•Mar 7, 2021
Very insightful and informative.
By Lorenza M
•Jan 20, 2023
great overview and speakers
By Muhamad A B A B
•Sep 17, 2020
Provide ample examples
By Alena T
•Jun 20, 2020
very interesting!
By Vikash K
•Sep 10, 2023
Usefull Course
By Qier W
•Jul 11, 2020
Great course!
By Gabriel R
•Sep 22, 2021
GREAT !
By Amirah a J
•Oct 18, 2022
-()
By Sewati P
•Sep 7, 2022
Good
By Mohamed T H
•Jul 24, 2020
Much better than the Drug Discovery and Drug Development courses in this specialization. In particular, the 2nd half of 3rd week was understandable and clearly taught. That part I think was later added and was not a part of the lectures otherwise used in these courses. That section really showed the potential of these courses which unfortunately was not reached due to the lectures that were used. Most of the time the presentation slides were filled with so many texts that you would wonder if its a presentation or an article. This course was better than the previous two courses though. After completing the three courses I feel that these courses could be much better if the course providers would improve the presentations used. Nonetheless, the course was informative. But there's only so much that one can absorb with so busy slides with not so attractive layout.
By Zhuohong X
•Jan 10, 2024
This review is for the Drug Discovery, Development, and Commercialization. The pluses are that industrial people came to talk about the real scenarios and trends they have seen. The big negative here is that these recordings were super outdated. They were recorded around 2013 (some are around 2016). Ten years in pharma is a long time. They should have updated these courses because of all the advancement in gene therapies, biologics, biosimilars, etc. Another negative is this is a one-way teaching. It is lacking in interaction. The discussion forum is not monitored and the post volume is very low (~30). This course does spark more interests from me. Now I have understood the pharma industry in 2013, I want to get more up-to-date understanding, just like I have read the beginning of the story and look forward to hearing more about how it goes.
By Dauletbekov
•Jan 2, 2020
The course is exremely useful and packs a lot of knowledge, however it's regrettable that the course was made in 2013-2014, and since then it was not updated. The pauses at the beginning of videos make you unsure whether you hit the right button, so I think that videos could be better edited. I found that lectures with Remi Brouard were not focussed and sometimes repetitive with what Dr Ettouti said already on industry collaboration. Overall, I found the course extremely useful, providing lot of insightful knowledge.
By Kierstin L
•Aug 23, 2017
Etouillie was great and his experience commentary made the course more interesting. His biosimilar section is highly pertinent to the US current situation with lawsuits flying every which way. I do wish more regulatory process steps were included. The start up success last section was not helpful. More just seemed like a quick review article one could read about an approved drug and the story of someone bragging about how lucky they were.
By Danna F M
•Sep 29, 2019
The course was very interesting and cover differents topics to give me an overview of drug commercialization in USA. In addition, the experiences shared from the each professor was excelent. However, I didn't know that the majority of topics were made in 2013. So this information was missing when I applied for this course.
By George L
•Mar 7, 2021
I found this course to be very engaging and informative about the Drug Development Process. However, most of the information is outdated - the course was recorded in 2015 and a lot has changed in pharma since then. I would give it a 5-stare rating if I had taken the course say 4-5 years ago.
By Dei M M L
•Dec 26, 2021
It is an excellent course from Coursera for learning on strategies for drug commercialization including pharmacoeconomics and how pharmaceuticals partners with other stakeholders to accomplish this.
By Alexander B
•Nov 2, 2020
Most of materials are quite outdated and also quality of presentations sometimes was not that good.
By Richik N M
•Jul 19, 2020
Not enough materials on HEOR and Phase IV studies. Week 4's lectures were redundant.
By Saudamini R
•Jun 8, 2020
Its a wonderful course, but i would request the faculty to include more recent data
By m_taisir k
•Oct 24, 2017
some lectures are not understand
but generally
thank you
By Meg R
•Jun 27, 2024
The managed markets data was old, needs to be updated.